Epigenetic approaches for bipolar disorder drug discovery

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Opinion on Drug Discovery

• Publication date

  2014-07-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/17460441.2014.922537PMID 24875048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA Therapeutics.

  2015cited by this paper
• Decreased global methylation in patients with bipolar disorder who respond to lithium.

  2014cited by this paper
• Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next

  2014cited by this paper
• Childhood maltreatment and methylation of the glucocorticoid receptor gene NR3C1 in bipolar disorder.

  2014cited by this paper
• Antidepressants and mood stabilizers effects on histone deacetylase expression in C57BL/6 mice: Brain region specific changes.

  2013cited by this paper
• Effects of sodium butyrate in animal models of mania and depression: implications as a new mood stabilizer.

  2013cited by this paper
• Histone deacetylases as targets for treatment of multiple diseases.

  2013cited by this paper
• HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner

  2013cited by this paper
• Affective disorders and risk of developing dementia: systematic review

  2013cited by this paper
• H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression.

  2013influential reference
• Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania.

  2013cited by this paper
• Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease

  2013cited by this paper
• The XY Gene Hypothesis of Psychosis: Origins and Current Status

  2013cited by this paper
• Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors.

  2013cited by this paper
• Toxicological and metabolic considerations for histone deacetylase inhibitors

  2013influential reference
• A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests

  2013cited by this paper
• Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder

  2013cited by this paper
• Treatment of bipolar disorder.

  2013cited by this paper
• Differential Expression of Exosomal microRNAs in Prefrontal Cortices of Schizophrenia and Bipolar Disorder Patients

  2013cited by this paper
• Effects of sodium butyrate on oxidative stress and behavioral changes induced by administration of D-AMPH.

  2013cited by this paper
• Programming of DNA methylation patterns.

  2012cited by this paper
• Evidence‐based options for treatment‐resistant adult bipolar disorder patients

  2012cited by this paper
• Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels.

  2012cited by this paper
• Selective DNA Methylation of BDNF Promoter in Bipolar Disorder: Differences Among Patients with BDI and BDII

  2012cited by this paper
• Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients

  2012cited by this paper
• Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients

  2012cited by this paper
• HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

  2012cited by this paper
• Altered gene expression of histone deacetylases in mood disorder patients

  2012cited by this paper
• Epigenetic regulation on GABRB2 isoforms expression: developmental variations and disruptions in psychotic disorders.

  2012cited by this paper
• A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder

  2012influential reference
• The role of DNA methylation in the pathogenesis and treatment of cancer.

  2012influential reference
• MicroRNA-134 plasma levels before and after treatment for bipolar mania.

  2011cited by this paper
• Epigenetic management of major psychosis

  2011cited by this paper
• ippocampal-dependent antidepressant-like activity of histone deacetylase nhibition erbert

  2011cited by this paper
• the epigenetics of non-coding rnA

  2011cited by this paper
• Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties

  2011cited by this paper
• Altered sirtuin deacetylase gene expression in patients with a mood disorder.

  2011cited by this paper
• Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder.

  2011cited by this paper
• DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.

  2011cited by this paper
• MicroRNA therapeutics

  2011cited by this paper
• Handbook of epigenetics : the new molecular and medical genetics

  2011cited by this paper
• Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder.

  2011influential reference
• Histone Deacetylases and Mood Disorders: Epigenetic Programming in Gene‐Environment Interactions

  2011influential reference
• Behavioral and neurochemical effects of sodium butyrate in an animal model of mania

  2011cited by this paper
• Neuroanatomical Profile of Antimaniac Effects of Histone Deacetylases Inhibitors

  2011cited by this paper
• Hypomethylation of the serotonin receptor type‐2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder

  2011cited by this paper
• Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins

  2011cited by this paper
• Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder

  2011cited by this paper
• Analysis of the GAD1 promoter: trans-acting factors and DNA methylation converge on the 5' untranslated region.

  2011cited by this paper
• Epigenetic GABAergic targets in schizophrenia and bipolar disorder.

  2011influential reference
• Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders

  2011influential reference
• Cognitive impairment in bipolar disorder.

  2011cited by this paper
• Rapid-cycling bipolar disorder: cross-national community study

  2010cited by this paper
• MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders.

  2010cited by this paper
• Epigenetics and gene expression

  2010cited by this paper
• Is There a Future for Histone Deacetylase Inhibitors in the Pharmacotherapy of Psychiatric Disorders?

  2010cited by this paper
• Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression

  2010cited by this paper
• Altered gene expression of histone deacetylases in mood disorder patients.

  2010cited by this paper
• Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling.

  2009cited by this paper
• Antipsychotic subtypes can be characterized by differences in their ability to modify GABAergic promoter methylation.

  2009cited by this paper
• Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population.

  2009influential reference
• Bipolar disorder: from genes to behavior pathways.

  2009cited by this paper
• The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors

  2009influential reference
• Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers

  2009cited by this paper
• Histone Deacetylase Inhibitors

  2009cited by this paper
• The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons

  2009cited by this paper
• Global leukocyte DNA methylation is not altered in euthymic bipolar patients.

  2009cited by this paper
• MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment.

  2009cited by this paper
• The future of genetics in psychology and psychiatry: microarrays, genome-wide association, and non-coding RNA.

  2009cited by this paper
• Differential methylation of the X‐chromosome is a possible source of discordance for bipolar disorder female monozygotic twins

  2008cited by this paper
• The loss of serendipity in psychopharmacology.

  2008cited by this paper
• Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition

  2008cited by this paper
• Rapid cycling bipolar disorder--diagnostic concepts.

  2008cited by this paper
• Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

  2008cited by this paper
• Pharmacoepigenetics and pharmacoepigenomics.

  2008cited by this paper
• Epigenomic profiling reveals DNA-methylation changes associated with major psychosis.

  2008cited by this paper
• Isoform-selective histone deacetylase inhibitors.

  2008cited by this paper
• Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins

  2008cited by this paper
• Role of Epigenetics in Mental Disorders

  2008cited by this paper
• [On bipolar disorder].

  2008influential reference
• Kaplan & Sadock s synopsis of psychiatry : behavioral sciences/clinical psychiatry / Benjamin James Sadock, Virginia Alcott Sadock

  2007cited by this paper
• The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?

  2007cited by this paper
• The role of epigenetics in mental disorders.

  2007cited by this paper
• Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder.

  2007influential reference
• Novel Therapeutics for Depression: L-methylfolate as a Trimonoamine Modulator and Antidepressant-Augmenting Agent

  2007cited by this paper
• Kaplan Sadock Comprehensive Textbook of Psychiatry

  2007cited by this paper
• Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action

  2006cited by this paper
• The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases

  2006cited by this paper
• Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.

  2006cited by this paper
• Treatment-resistant bipolar disorder

  2006cited by this paper
• Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

  2006cited by this paper
• Epigenetic therapy--a new development in pharmacology.

  2006cited by this paper
• Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population.

  2006cited by this paper
• Psychiatry and the pharmaceutical industry: Who pays the piper?

  2005cited by this paper
• The increasing medical burden in bipolar disorder.

  2005influential reference
• S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production.

  2005cited by this paper
• In psychosis, cortical interneurons overexpress DNA-methyltransferase 1.

  2005influential reference
• 14.8 MOOD DISORDERS: TREATMENT OF BIPOLAR DISORDERS

  2004cited by this paper
• Bipolar disorder.

  2004cited by this paper
• Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons

  2004cited by this paper

• Promises and challenges in pharmacoepigenetics

  2023cites this paper
• Genomics in Treatment Development.

  2023cites this paper
• Dengue and Psychiatry: Manifestations, Mechanisms, and Management Options

  2021cites this paper
• The efficacy of HDAC inhibitors in neoplasm treatment

  2020cites this paper
• Role of epigenetic regulatory enzymes in animal models of mania induced by amphetamine and paradoxical sleep deprivation

  2020influential citation
• Targeting histone modifications in psychotic disorders

  2020cites this paper
• Irradiation by γ-rays reduces the level of H3S10 phosphorylation and weakens the G2 phase-dependent interaction between H3S10 phosphorylation and γH2AX.

  2018cites this paper
• Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician’s perspective

  2018cites this paper
• The utility of pharmacogenetic testing to support the treatment of bipolar disorder

  2018cites this paper
• Epigenetic Drugs for Mood Disorders.

  2018cites this paper
• Epigenetic biomarkers in neuropsychiatric disorders

  2017cites this paper
• Experimental drugs for bipolar psychosis

  2016cites this paper
• Sodium butyrate has an antimanic effect and protects the brain against oxidative stress in an animal model of mania induced by ouabain.

  2016cites this paper
• Dissecting bipolar disorder complexity through epigenomic approach

  2016cites this paper
• Epigenetika helburu duten sendagaiak (Drugs targeting epigenetics

  year unknowncites this paper